Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.
Publication type: Journal Article
Tanne JH.
Merck faces ongoing claims after Texan ruling on rofecoxib.
BMJ 2005 Sep 3; 331:(7515):471
http://bmj.bmjjournals.com/cgi/content/full/331/7515/471
Please
Register
(read more)
then
Log in
for free access to more features of this website.
Forgot your username or password?
You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.
PharmedOut’s annual conference: Missing The Target: When Practitioners Harm More Than Heal
No Free Lunch is merging with Healthy Skepticism
Conference program: Pharma Knows Best? Managing Medical Knowledge
Prescrire’s proposals for France’s national conference on medicines policy
Pharmed Out Conference ‘Pharma Knows Best? Managing Medical Knowledge’
